Where can I buy larotrectinib and what are the purchasing channels?

Larotrectinib is an innovative anti-cancer drug that is a tyrosine kinase inhibitor and is widely used in adult and pediatric patients carrying NTRK gene fusions. NTRKGene fusion is a rare genetic abnormality found in a variety of cancer types, including soft tissue sarcoma, infantile fibroma, lung cancer, and more.

Larotrectinib has been launched in China and has not yet been included in medical insurance. Since it has not been launched in China for a long time, it may be difficult to purchase it in hospitals. For specific conditions, it is recommended to consult the local hospital pharmacy.

In foreign markets, larotrectinib has two options: original drug and generic drug. Original drugs include the German version, the American version, the European version and the Hong Kong version, and the price is about 10,000 to 20,000 yuan. In comparison, generic drugs are much cheaper. There are Lao and Bangladeshi versions of generic drugs, and the price is around two to three thousand. It is worth noting that the ingredients of original drugs and generic drugs are basically the same.

The drug is unique in that it highly selectively targets the NTRK kinase, effectively inhibiting the growth and spread of tumors by blocking this abnormal signaling pathway. Clinical trial results show that larotrectinib exhibits significant anti-tumor efficacy in patients carrying NTRK gene fusions, including tumor shrinkage, cessation of progression, and even complete disappearance.

Before using larotrectinib, patients usually need to undergo genetic testing to determine whether their tumors carryNTRK gene fusions to determine whether they are suitable for treatment with this drug. This personalized treatment strategy provides patients with more precise and effective treatment options.

The safety and tolerability of larotrectinib have been verified in clinical trials, and common adverse reactions include mild fatigue, dizziness and nausea. The launch of the drug provides patients with an innovative treatment approach, especially for some rare tumor types, and brings new hope.